nachbörslich zu CHINA SUN:
Miscellaneous * Asterisks denote mandatory information "DISCLAIMER:- This announcement was prepared and issued by the belowmentioned listed issuer to the Exchange. The Exchange assumes no responsibility for the correctness of any of the statements made, opinions expressed or reports contained in this announcement and is posting this announcement on SGXNET for the sole purpose of dissemination only. In the event of any queries or clarification required in respect of any matters arising from this announcement, such queries are to be made to the listed issuer directly and not to the Exchange. The Exchange shall not be liable for any losses or damages howsoever arising as a result of the circulation, publication and dissemination of this announcement." Name of Announcer * CHINA SUN BIOCHEM TECH GP CO. Company Registration No. CT-136769 Announcement submitted on behalf of CHINA SUN BIOCHEM TECH GP CO. Announcement is submitted with respect to * CHINA SUN BIOCHEM TECH GP CO. Announcement is submitted by * SUN GUIJI Designation * EXECUTIVE CHAIRMAN AND CEO Date & Time of Broadcast 03-Jul-2006 17:55:45 Announcement No. 00085 >> Announcement Details The details of the announcement start here ... Announcement Title * 1% Convertible Notes due 2007 ("the Convertible Notes")
Description § The Board of Directors of the Company is pleased to announce the following:
(a) that an investor of the Convertible Notes has exercised its conversion rights in respect of an aggregate of S$3 million in Convertible Notes on 19 June 2006 at an exercise price of S$0.55 per share of par value HK$0.25 each ("Share") in the capital of the Company. As a result, the issued share capital of the Company has increased by 5,454,545 Shares. Following the conversion, the issued share capital of the Company comprises 776,095,967 Shares; and
(b) that an investor of the Convertible Notes has exercised its conversion rights in respect of an aggregate of S$3 million in Convertible Notes on 23 June 2006 at an exercise price of S$0.55 per share of par value HK$0.25 each ("Share") in the capital of the Company. As a result, the issued share capital of the Company has increased by 5,454,545 Shares. Following the conversion, the issued share capital of the Company comprises 781,550,512 Shares.
|